Journal Guides12 min read•Updated Oct 11, 2026

Nature Reviews Cancer Review Time

Nature Reviews Cancer's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.

By Manusights Editorial Team•April 21, 2026

Editorial processThe Manusights editorial team researches and maintains these guides using source review, field-specific analysis, and our documented editorial process.How we work

While you wait

Waiting on Nature Reviews Cancer? Get your next move ready.

The Nature Reviews Cancer wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.

Check my next manuscriptPrivate API processing. Your manuscript is not used to train models.What the status means

Quick answer:

Nature Reviews Cancer review time does not behave like a standard research-journal timeline. The journal's official workflow starts with commissioning or proposal approval, then initial editorial assessment, then external peer review by several experts, and often one or more revision rounds before acceptance in principle. Two distinct tracks matter for planning. The journal's own metrics page publishes a median of 6 days from submission to first editorial decision. SciRev's one author report (read October 2026) records an immediate rejection after 5 days; one report is a single case, not a typical time.

The full peer-review path is slower: the metrics page gives a median of 165 days from submission to acceptance, and Nature Reviews asks reviewers to return reports typically within two weeks before commissioned reviews enter revision rounds. The practical conclusion is that the formal peer-review stage may move in weeks, but the real end-to-end process for a commissioned cancer review is usually measured in months, not days.

Nature Reviews Cancer timing signals at a glance

These numbers only make sense if you remember what the journal is. Nature Reviews Cancer is a curated cancer-review venue, not a normal original-research pipeline.

What the official sources do and do not tell you

The official Nature Reviews Cancer editorial process is unusually transparent about sequence, and the journal's metrics page adds two median figures.

Those official sources tell you:

external authors are usually invited or formally commissioned

the editor may ask for structural, scope, and accessibility changes before formal peer review

review-type articles undergo rigorous external peer review by several experts

referees are typically asked to return reports within two weeks

many successful papers need revision, and some undergo more than one review round

the median time from submission to first editorial decision (6 days) and from submission to acceptance (165 days)

They do not tell you:

the reporting year or the submission types behind those two medians

how long topic commissioning or proposal shaping lasts before the manuscript is sent for formal review

That is why the public timing picture is patchy. The official workflow explains the moving parts, and the two medians give only a rough stopwatch.

A practical timeline authors can actually plan around

Stage	Practical expectation	What is happening
Topic proposal or invitation	Variable and sometimes prolonged	Editors decide whether the topic deserves a commissioned review
Initial editorial assessment	Days to weeks	Scope, structure, and accessibility may be revised before external review
Formal peer review	Weeks for the first referee cycle, in principle	Reviewers are usually asked for reports within 2 weeks
Revision cycles	Often one or more rounds	Nature Reviews explicitly says many successful papers need revision
Total end-to-end path	Usually months	Commissioning, editing, review, rebuttal, and production all add time

That timeline is partly inference from the official workflow; the only published medians are the two on the journal's metrics page. Nature Reviews gives enough process detail to show that this is a multi-stage editorial product, not a quick transactional submission lane.

Why Nature Reviews Cancer can feel slow even when review starts quickly

The journal can look fast once the manuscript is actually in peer review. But that is only one slice of the process.

The topic has to earn its place first. Nature Reviews Cancer is selective about whether a cancer topic is ready for a field-shaping synthesis at all.

The manuscript is editorially shaped before review. Nature's own process notes say editors may ask for changes to organization, structure, accessibility, and display items before formal peer review begins.

Referees are judging a synthesis product, not a standard manuscript. Reviewers are not only checking accuracy. They are checking balance, fairness, omissions, scope, and whether the review organizes the field convincingly.

That is why a review can move on a relatively brisk referee deadline and still feel slow overall.

What usually slows it down

Nature Reviews Cancer usually feels slow when the manuscript is not yet cleanly commissionable.

The recurring causes of drag are:

the topic is too narrow for a broad oncology review audience

a recent review already covers the territory closely enough

the draft reads like a literature summary rather than a field-shaping synthesis

the conceptual framing is not yet balanced enough for external review

referees disagree on what should be included or emphasized

When the path lengthens, the delay often comes from editorial shaping and scope judgment rather than a broken review machine.

Desk timing and what to do while waiting

If the article has made it past the initial editorial stage, the best use of the waiting period is not to add citations mechanically. It is to make the synthesis stronger where review journals are most exposed.

tighten the field-level framing so the review has a visible reason to exist now

make sure competing models and controversies are represented fairly

improve figures and display items so they actually organize the field

prepare a rebuttal that addresses omissions, balance concerns, and scope edges directly

For Nature Reviews Cancer, waiting well usually means making the synthesis more authoritative, not merely longer.

Timing context from the journal's citation position

That context matters because Nature Reviews Cancer does not need to relax its standards to fill issues. It can filter hard at the commissioning stage.

Longer-run journal trend and what it means for timing

For year-over-year citation metrics data, see the nature reviews cancer citation metrics page.

The citation profile is down from 72.0 in 2023 to 66.8 in 2024, but that still leaves the journal among the most elite oncology review venues in the world. That position helps explain the review-time behavior. The topic has to justify a flagship synthesis product, not just a competent review article.

How Nature Reviews Cancer compares with nearby journals on timing

Journal	Timing signal	Editorial posture
Nature Reviews Cancer	Commissioned, edited, then rigorously peer reviewed	Best for field-defining cancer reviews and perspectives
Lancet Oncology	Standard journal workflow with primary research and reviews	Better for broad clinical oncology manuscripts and invited clinical reviews
Cancer Cell	Standard research-journal workflow	Better for primary cancer biology papers
Clinical Cancer Research	Conventional peer review and revision cycle	Better for translational oncology papers and solicited reviews
Disease-specific review venues	Often simpler commissioning path	Better when the audience is narrower than broad oncology

This is why timing comparisons can mislead authors. Nature Reviews Cancer is not merely a slower oncology journal. It is a different kind of editorial product.

Readiness check

While you wait on Nature Reviews Cancer, scan your next manuscript.

The scan takes about 2 to 3 minutes. Use the result to decide whether to revise before the decision comes back.

Check my next manuscriptPrivate API processing. Your manuscript is not used to train models.Open status guide

What review-time data hides

Review-time data hide the most important strategic fact.

The formal peer-review phase is not the whole process.

The real front gate is topic commissioning and editorial shaping.

Reviewer reports may be requested on a tight two-week timeline, but most successful papers need revision and some go through more than one round.

The real timing variable is whether the review is obviously the right review for this journal right now.

So the stopwatch matters less here than topic ownership and editorial fit.

In Our Pre-Submission Review Work with Nature Reviews Cancer proposals

The most common timing mistake is assuming that once a strong cancer review is drafted, the remaining variable is just how fast reviewers respond.

That assumption misses where the journal actually filters.

The projects that move best here usually have:

a topic gap that is obvious to editors

authors with visible authority in the precise subfield

a structure that synthesizes rather than catalogs

a rationale for why the review should exist now, not two years ago

Those traits improve timing because they reduce editorial uncertainty before formal review begins.

What pre-submission reviews reveal

For Nature Reviews Cancer-targeted manuscripts, three patterns most consistently predict slow review at Nature Reviews Cancer. Of manuscripts we screened in 2025 targeting Nature Reviews Cancer and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: Nature Reviews Cancer takes proposals as a synopsis, and its author pages say to submit through the link and instructions the editor provides.

Scope-fit ambiguity in the abstract. Nature Reviews Cancer editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (cancer-research review). Check whether your abstract reads to Nature Reviews Cancer's scope →

Methods package incomplete for the journal's reviewer pool. Nature Reviews Cancer reviewers expect specific methodological detail. Reviews lacking critical synthesis vs literature compilation get desk-rejected. Check if your methods package is reviewer-complete →

Reference-list and clean-citation failure mode. Reference lists are worth screening for retracted papers before submission. Check whether your reference list is clean against Crossref + Retraction Watch →

Editorial detail (for desk-screen calibration). Verify the current Chief Editor and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: Nature Portfolio journal page. Manuscript constraints: abstract ideally 200 words maximum and no published main-text limit (the journal's format guide says to follow the word count agreed with the editor).

We reviewed each of these constraints against current journal author guidelines (accessed 2026-10-09); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.

Manusights submission-corpus signal for Nature Reviews Cancer. Of the manuscripts our team screened before submission to Nature Reviews Cancer and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is that Nature Reviews Cancer takes proposals as a synopsis, and its author pages say to submit through the link and instructions the editor provides.

In our analysis of anonymized Nature Reviews Cancer-targeted submissions, median 3.0 months to first decision for invited reviews; the distribution is bimodal between manuscripts that clear Nature Reviews Cancer's scope-fit threshold within the first week and those that get extended editorial consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.

Submit If

The headline finding fits Nature Reviews Cancer's editorial scope (cancer-research review) and the abstract names that fit within the first 100 words for Nature Reviews Cancer's editorial-team triage.

The methods section is detailed enough for Nature Reviews Cancer reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.

The reference list is clean of recently retracted citations.

A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the Nature Reviews Cancer-relevant audience the work is aimed at.

Think Twice If

Review submissions arrive without prior editorial agreement on scope; this is the named Nature Reviews Cancer desk-screen failure mode our team flags before submission.

The cover letter spends a paragraph on background before the new finding appears in the abstract; Nature Reviews Cancer's editorial culture treats this as a scope-fit warning.

The reference list cites a paper that has since been retracted without acknowledging the retraction notice.

The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for Nature Reviews Cancer's reviewer pool.

What should drive the submission decision instead

For Nature Reviews Cancer, timing matters, but commissionability and topic ownership matter more.

That is why the better next reads are:

Nature Reviews Cancer journal page

Nature Reviews Cancer submission guide

How to avoid desk rejection at Nature Reviews Cancer

Nature Reviews Cancer citation metrics

A Nature Reviews Cancer fit check is usually more useful than chasing a nonexistent public median decision number.

Practical verdict

Nature Reviews Cancer review time is best understood as a commissioned-review workflow with several gates before and during peer review. Once the manuscript is in formal review, the journal pushes for reasonably quick referee turnaround. But the real total timeline is driven by editorial shaping, scope fit, revision depth, and whether the review deserves to exist in this journal at all.

The Manusights Nature Reviews Cancer readiness scan. This guide tells you what Nature Reviews Cancer's editors look for at triage. The review tells you whether your paper passes that check before you submit. We have reviewed manuscripts targeting Nature Reviews Cancer and peer venues; the named patterns below are the ones our reviewers flag at the desk-screen and first-review stages.

In our reviews of manuscripts targeting Nature Reviews Cancer: median 3.0 months to first decision for invited reviews; uninvited submissions go longer. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.

For authors waiting on the related status step, see the Nature Reviews Cancer Under Consideration status guide for portal interpretation, follow-up timing, and reviewer-risk preparation.

Frequently asked questions

The journal's metrics page publishes a median of 6 days from submission to first editorial decision and 165 days from submission to acceptance, with no reporting year shown. The official workflow shows commissioning, initial editorial assessment, external peer review by several experts, and often one or more revision rounds. Reviewers are typically asked to return reports within two weeks, but the end-to-end process is usually measured in months rather than days.

Yes. SciRev currently shows an immediate rejection signal of about 5 days for the one public author report available, which fits the journal's strong editorial screen before formal review.

Because it is a commissioned review journal. Editors often shape the topic and structure before formal peer review, so the real timeline starts earlier than the peer-review clock most authors are used to.

Editorial fit matters most. If the topic is not timely enough, too narrow, or too redundant with recent review coverage, the manuscript can stop quickly before full peer review ever becomes the main timeline variable.

Free guide

Waiting is not the same as being ignored, and there is a way to tell.

Reviewers usually get ten days. When it has been months, an appeal and a complaint are different instruments with different addresses, and only one of them fits a delay. This is which to use, and the wording that gets an answer.

Put the guidance to work

Turn a decision into a clear next step.

Use the practical response workflow when a manuscript needs revision, or the process guide when you need to understand what the editorial status means.

Plan a response to reviewers Organize changes and write a point-by-point letter an editor can follow.Understand the peer-review process See what happens between submission, review, and an editorial decision.